L-202-2020
Agreement ID
L-202-2020
Lead IC
NIAID
Exclusivity
Nonexclusive
External Party
International AIDS Vaccine Initiative, Inc.
Fiscal Year
2020
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-3169 Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
TAB-3169 Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
TAB-3386 Improvement of Broadly HIV-Neutralizing Antibodies; Anti-HIV-1 Antibody VRC01.23 for Prevention or Treatment of HIV Infection
TAB-3169 Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
TAB-3386 Improvement of Broadly HIV-Neutralizing Antibodies; Anti-HIV-1 Antibody VRC01.23 for Prevention or Treatment of HIV Infection